Cargando…
Treatments for early-stage Dupuytren’s disease: an evidence-based approach
Current treatments for Dupuytren’s disease are limited to late-stage disease when patients have developed flexion contractures and have impaired hand function. They all have limitations, including the risk of recurrence and complications. The use of treatments for early-stage disease, such as intral...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996772/ https://www.ncbi.nlm.nih.gov/pubmed/36638105 http://dx.doi.org/10.1177/17531934221131373 |